Website maintenance is scheduled for June 13-17, 2024. During this time, all ons.org content requiring login access will not be available. For help, contact help@ons.org.
Chimeric antigen receptor (CAR) T-cell therapy combines tumor-specific antigen recognition and T-cell immune fighting responses to target and destroy specific malignancies. Review this huddle card in a group or individually to learn more about chimeric antigen receptor (CAR) T -cell therapy.